日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting.

CXCR4 可诱导 CAR-T 细胞在耗竭后形成记忆,从而实现持久的白血病靶向治疗。

Itoh-Nakadai Ari, Liang Minggao, Shindo Michiho, Bibi Chen, Tomizawa-Murasawa Mariko, Fujiki Saera, Kaneko Akiko, Kanamaru Emi, Hashimoto Mari, Kajita Hiroshi, Ando Yoshinari, Kojima Miki, Moody Jonathan, Iwasaki Makoto, Takagi Shinsuke, Nakagawa Ryo, Agrawal Saumya, Amitani-Iijima Hanae, Sato Kaori, Sorimachi Yuriko, Suzuki Nahoko, Fukami Takehiro, Hanada Kazuharu, Morita Satoshi, Katsura Kazushige, Matsumoto Takehisa, Kobayashi Maiko, Kato Masahiko, Negishi Yasuyuki, Shirouzu Mikako, Najima Yuho, Takubo Keiyo, Hon Chung Chau, Uchida Naoyuki, Taniguchi Shuichi, Momozawa Yukihide, Carninci Piero, Shultz Leonard D, Saito Yoriko, de Hoon Michiel, Shin Jay W, Ishikawa Fumihiko

A novel quantitative method for CT assessment of bronchiectasis using AI-based airway segmentation and upper limits of normal airway caliber

一种利用人工智能气道分割和正常气道口径上限进行支气管扩张CT评估的新型定量方法

Tanabe, Naoya; Sato, Atsuyasu; Maetani, Tomoki; Sakamoto, Ryo; Fukui, Motonari; Masuda, Izuru; Kanasaki, Megumi; Handa, Tomohiro; Sato, Susumu; Morita, Satoshi; Hirai, Toyohiro

Age-Related Associations of Blood Pressure and Arterial Stiffness with Retinal Arterial Structure

血压和动脉硬度与视网膜动脉结构的年龄相关性

Xiang, Ran; Muraoka, Yuki; Kogo, Takahiro; Hidaka, Yu; Mori, Yuki; Hata, Masayuki; Miyake, Masahiro; Morita, Satoshi; Tabara, Yasuharu; Matsuda, Fumihiko; Tsujikawa, Akitaka

RAS/BRAF wild-type metastatic high-methylated colorectal cancer has gene expression patterns related to MSI-H and BRAF V600E mutant: a translational research

RAS/BRAF野生型转移性高甲基化结直肠癌具有与MSI-H和BRAF V600E突变相关的基因表达模式:一项转化研究

Wakayama, Shonosuke; Takahashi, Shin; Ouchi, Kota; Sakamoto, Yasuhiro; Denda, Tadamichi; Takashima, Atsuo; Komatsu, Yoshito; Nakamura, Masato; Ohori, Hisatsugu; Yamaguchi, Tatsuro; Kobayashi, Yoshimitsu; Baba, Hideo; Kotake, Masanori; Amagai, Kenji; Kondo, Hitoshi; Shimada, Ken; Yamada, Yasuhide; Sato, Atsushi; Yuki, Satoshi; Okita, Akira; Komine, Keigo; Watanabe, Mika; Morita, Satoshi; Ishioka, Chikashi

A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis

一项针对亚洲新诊断急性髓系白血病患者的吉瑞替尼联合化疗的I/II期研究:最终分析

Sawa, Masashi; Miyamoto, Toshihiro; Kim, Hee-Je; Hiramatsu, Yasushi; Cheong, June-Won; Ikezoe, Takayuki; Naoe, Tomoki; Akashi, Koichi; Morita, Satoshi; Kosako, Masanori; Shimura, Masaki; Terada, Wataru; Kadokura, Takeshi; Hill, Jason; Miyawaki, Shuichi; Gill, Stanley C; Heinloth, Alexandra; Hasabou, Nahla

Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study

根据同源重组缺陷状态分层的三阴性乳腺癌患者接受基于艾立布林的新辅助化疗的长期疗效:随机JBCRG-22研究的结果

Masuda, Norikazu; Yasojima, Hiroyuki; Bando, Hiroko; Yamanaka, Takashi; Shigematsu, Hideo; Takahashi, Masato; Nagai, Shigenori E; Ito, Mitsuya; Aruga, Tomoyuki; Tokiwa, Mariko; Imoto, Shigeru; Nakamura, Rikiya; Ishiguro, Hiroshi; Kawabata, Hidetaka; Saji, Shigehira; Haga, Hironori; Morita, Satoshi; Toi, Masakazu

Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trial

降低光动力疗法与安慰剂治疗中心性浆液性脉络膜视网膜病变(REPLAY试验):一项关键性双盲随机对照试验的原理和研究方案

Miyake, Masahiro; Takahashi, Ayako; Baba, Takayuki; Maruko, Ichiro; Ohnaka, Masayuki; Kuroda, Akiko; Tada, Harue; Hidaka, Yu; Ibi, Yumiko; Muraoka, Yuki; Ito, Tatsuya; Morita, Satoshi; Sakamoto, Taiji; Imai, Hisanori; Yamamoto, Shuichi; Iida, Tomohiro; Tsujikawa, Akitaka

Protocol for measuring lipid membrane fluidity in human iPSC-derived neural cells.

测量人类iPSC衍生神经细胞脂质膜流动性的方案。

Morita Satoshi, Kondo Takayuki, Inoue Haruhisa

Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease.

iPS细胞衍生多巴胺能细胞治疗帕金森病的I/II期试验

Sawamoto Nobukatsu, Doi Daisuke, Nakanishi Etsuro, Sawamura Masanori, Kikuchi Takayuki, Yamakado Hodaka, Taruno Yosuke, Shima Atsushi, Fushimi Yasutaka, Okada Tomohisa, Kikuchi Tetsuhiro, Morizane Asuka, Hiramatsu Satoe, Anazawa Takayuki, Shindo Takero, Ueno Kentaro, Morita Satoshi, Arakawa Yoshiki, Nakamoto Yuji, Miyamoto Susumu, Takahashi Ryosuke, Takahashi Jun

Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial

曲妥珠单抗-帕妥珠单抗联合艾立布林或紫杉烷类药物作为人表皮生长因子2阳性局部晚期/转移性乳腺癌的一线化疗方案:随机非劣效性III期EMERALD试验

Yamashita, Toshinari; Saji, Shigehira; Takano, Toshimi; Naito, Yoichi; Tsuneizumi, Michiko; Yoshimura, Akiyo; Takahashi, Masato; Tsurutani, Junji; Iwatani, Tsuguo; Kitada, Masahiro; Tada, Hiroshi; Mori, Natsuko; Higuchi, Toru; Iwasa, Tsutomu; Araki, Kazuhiro; Koizumi, Kei; Hasegawa, Hiroki; Uchida, Yohei; Morita, Satoshi; Masuda, Norikazu